Non-Invasive Biomarkers of NASH

Non-Invasive Biomarkers of NASH

The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH).  Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022. This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Break the Silence of Liver Disease

NASH (Non-Alcoholic Steatohepatitis) occurs when an abnormal amount of fat builds up in the liver. It is the most severe form of non-alcoholic fatty liver disease (NAFLD). NASH is linked to the triple epidemic of obesity, pre-diabetes, and diabetes. However, its symptoms are often non-specific to NASH, making it difficult to detect in the years …

Read more

Check the List. Are you at Risk for NASH?

Non-alcoholic steatohepatitis (NASH) is a form of fatty liver disease where extra fat builds up in the liver and causes it to swell and become damaged. It is a modern-day epidemic of surging waistlines and unhealthy lifestyles. NASH takes years to develop and has little to no symptoms. It can cause irreversible damage leading to …

Read more

Fibroscan detecting silent liver diseases

Learning More About FibroScan Technology

Endeavor Clinical Trials is currently enrolling participants for a free FibroScan, which painlessly detects scarring and fatty liver without a liver biopsy. Since certain conditions put you at a higher risk for these liver issues, we wanted to take the time to explain how the technology works, and why you should get one today! How FibroScan …

Read more

Don’t Let Your NASH Turn into Cirrhosis

It is estimated that 20% of those with nonalcoholic fatty liver disease (NAFLD) also have NASH. There are four stages of NAFLD, and NASH is the halfway point to the last step, which is cirrhosis. The damage caused by cirrhosis is permanent and is not reversible. However, by seeking treatment early and making specific lifestyle changes, you …

Read more

STUDIES ARE ENROLLING NOW!

Nonalcoholic Fatty Liver Disease (NAFLD)

NAFLD is the most common form of chronic liver disease in the US. Find out if you’re at risk today by taking part in a clinical trial enrolling now. 

Knee Pain

Apply to participate in a study of an investigational pain medication following a knee replacement.

Smoking Study

Are you a current smoker? You may qualify for a clinical trial evaluating various heated tobacco products.